E-cadherin expression in transitional cell carcinomas

被引:4
|
作者
Szekely, Eszter
Torok, Virag
Szekely, Tamas
Riesz, Peter
Romics, Imre
机构
[1] Semmelweis Univ, Dept Pathol 2, H-1091 Budapest, Hungary
[2] Semmelweis Univ, Dept Urol, H-1091 Budapest, Hungary
关键词
bladder cancer; E-cadherin; transitional cell carcinoma;
D O I
10.1007/BF02893447
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The authors analyzed the expression of E-cadherin, one of the most important cell adhesion molecules, on paraffin sections of tumors of bladder cancer patients. The aim of the study was to see whether there is any association between E-cadherin expression and tumor grade, stage, age and gender of the patients, number of recurrences, or overall survival. The samples were examined in 51 primary bladder transitional cell carcinomas (TCC) of 50 patients, resected by transurethral resection (TUR) between January 1, 1996 and January 1, 1997. Immunoreactions were performed with monoclonal anti-human E-cadherin antibody. Forty of the fifty patients could be clinically followed. The analysis of the results on these forty patients was performed by contingency analysis and significance was assessed by. 2 test. No significant association between E-cadherin expression and tumor grade, stage, age or gender of the patients, the number of recurrences, or overall survival could be seen.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [41] Expression of SIP1 in oral squamous cell carcinomas: Implications for E-cadherin expression and tumor progression
    Maeda, G
    Chiba, T
    Okazaki, M
    Satoh, T
    Taya, Y
    Aoba, T
    Kato, K
    Kawashiri, S
    Imai, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (06) : 1535 - 1541
  • [42] E-cadherin/β-catenin immunoexpression in thyroid carcinomas
    Ivanova, K.
    Onal, E.
    Ananiev, J.
    Vlaikova, T.
    Gulubova, M.
    VIRCHOWS ARCHIV, 2012, 461 : S100 - S101
  • [43] Correlation of E-cadherin expression with clinicopathological data in patients suffering from transitional cell carcinoma of the bladder
    Charalabopoulos, K
    Tsambalas, S
    Syrigos, K
    Giannakopoulos, X
    Kalfakakou, V
    Kiortsis, D
    Alamanos, J
    Charalabopoulos, A
    Evangelou, A
    Sofikitis, N
    Agnantis, NJ
    EXPERIMENTAL ONCOLOGY, 2003, 25 (03): : 180 - 185
  • [44] E-cadherin expression in clear cell renal cell carcinoma
    Giusca, S. E.
    Lozneanu, L.
    Caruntu, I. -D.
    Danciu, M.
    Cojocaru, E.
    VIRCHOWS ARCHIV, 2015, 467 : S276 - S276
  • [45] Differental loss E-cadherin in breast carcinomas
    Berindan, I
    Balacescu, O
    Risca, R
    Neagoe, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S110 - S110
  • [46] E-CADHERIN EXPRESSION IN BASAL-CELL CARCINOMA
    PIZARRO, A
    BENITO, N
    NAVARRO, P
    PALACIOS, J
    CANO, A
    QUINTANILLA, M
    CONTRERAS, F
    GAMALLO, C
    BRITISH JOURNAL OF CANCER, 1994, 69 (01) : 157 - 162
  • [47] E-cadherin expression in thymomas
    Yang, WI
    Yang, KM
    Hong, SW
    Kim, KD
    YONSEI MEDICAL JOURNAL, 1998, 39 (01) : 37 - 44
  • [48] Emergence of undifferentiated rat tracheal cell carcinomas, but not squamous cell carcinomas, is associated with a loss of expression of E-cadherin and of gap junction communication
    TerzaghiHowe, M
    Chang, GW
    Popp, D
    CARCINOGENESIS, 1997, 18 (11) : 2043 - 2050
  • [49] E-CADHERIN EXPRESSION - A COUNTERBALANCE FOR CANCER CELL INVASION
    MAREEL, M
    VLEMINCKX, K
    VERMEULEN, S
    BRACKE, M
    VANROY, F
    BULLETIN DU CANCER, 1992, 79 (04) : 347 - 355
  • [50] E-cadherin expression in adenomyosis
    Romadanova, J. Julia
    Popova, Olga
    Gorbacheva, Julia
    Voloshchuk, Irina
    VIRCHOWS ARCHIV, 2007, 451 (02) : 402 - 402